» Articles » PMID: 10322418

Hsp90 & Co. - a Holding for Folding

Overview
Specialty Biochemistry
Date 1999 May 14
PMID 10322418
Citations 162
Authors
Affiliations
Soon will be listed here.
Abstract

Hsp90 is an abundant molecular chaperone that is involved in the folding of a defined set of signalling molecules including steroid-hormone receptors and kinases. Recent in vitro experiments suggest that Hsp90 contains two different binding sites for non-native proteins, which allow it to combine the properties of a promiscuous chaperone with those of a dedicated folding-helper protein. Significant progress has been made in analysing co-chaperones, which form defined, substrate-dependent complexes with Hsp90 in vivo. Structural studies have identified the ATP-binding site in the N-terminal domain of Hsp90, which can be blocked by high-affinity inhibitors. Although a detailed understanding of the mechanism of Hsp90 action is still lacking, recent advances suggest that the protein is the centre of a dynamic, multifunctional and multicomponent chaperone machinery that extends the limits of protein folding in the cell.

Citing Articles

Heat Shock Response and Heat Shock Proteins: Current Understanding and Future Opportunities in Human Diseases.

Singh M, Shin Y, Ju S, Han S, Choe W, Yoon K Int J Mol Sci. 2024; 25(8).

PMID: 38673794 PMC: 11050489. DOI: 10.3390/ijms25084209.


MDM2 regulates the stability of AR, AR-V7, and TM4SF3 proteins in prostate cancer.

Khatiwada P, Rimal U, Han Z, Shemshedini L Endocr Oncol. 2024; 4(1):e230017.

PMID: 38410785 PMC: 10895308. DOI: 10.1530/EO-23-0017.


Heat Shock Protein 70 and 90 Family in Prostate Cancer.

Fu X, Liu J, Yan X, DiSanto M, Zhang X Life (Basel). 2022; 12(10).

PMID: 36294924 PMC: 9605364. DOI: 10.3390/life12101489.


Crystal structure of the middle and C-terminal domains of Hsp90α labeled with a coumarin derivative reveals a potential allosteric binding site as a drug target.

Peng S, Woodruff J, Pathak P, Matts R, Deng J Acta Crystallogr D Struct Biol. 2022; 78(Pt 5):571-585.

PMID: 35503206 PMC: 9063849. DOI: 10.1107/S2059798322002261.


Immunogenic Cell Death in Cancer Therapy.

Troitskaya O, Novak D, Richter V, Koval O Acta Naturae. 2022; 14(1):40-53.

PMID: 35441043 PMC: 9013441. DOI: 10.32607/actanaturae.11523.